Product information

Current status:

Cancelled Post Market

Current status date:

2021-11-01

Original market date: ^{See footnote 1}

2011-02-28

Lot number: ^{See footnote 2}

21C27

Expiry date: ^{See footnote 2}

2023-03-31

Product name:

AURALGAN

DIN:

02332477 Electronic product monograph is not available

Company:

PALADIN PHARMA INC.
100 Blvd Alexis-Nihon, Suite 600
Saint-Laurent
Quebec
Canada H4M 2P2

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Otic

Number of active ingredient(s):

2

Schedule(s):

OTC

American Hospital Formulary Service (AHFS): ^{See footnote 3}

52:16.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

S02DA30 COMBINATIONS

Active ingredient group (AIG) number:^{See footnote5}

0204904002